Mixed Herbal Extract for Allergic Disease Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for allergic diseases, such as bronchial asthma and atopic dermatitis, often come with side effects and limited efficacy, necessitating the development of natural compounds with low toxicity and excellent therapeutic effects.
Innovation Solution
A pharmaceutical composition comprising a mixed extract of two or more selected from Asiasarum root, Platycodon root, and Cinnamomi ramulus, which is administered to prevent or treat allergic diseases by inhibiting Th2 cell differentiation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for allergic diseases are used, then therapeutic effects are achieved, but side effects occur and efficacy is limited
Solution Approach 1:
The patent uses a composite herbal formulation combining extracts from Asiasarum root, Platycodon root, and Cinnamomi ramulus in specific proportions (Asiasarum:Platycodon:Cinnamomi = 1:2:2). This composite approach synergistically combines the anti-allergic properties of multiple herbs to enhance therapeutic efficacy while reducing side effects compared to single-herb or conventional treatments
Solution Approach 2:
The patent optimizes the extraction parameters including solvent concentration (70% ethanol), extraction temperature (60-70°C), extraction time (3 hours), and herbal ratio (1:2:2) to maximize the therapeutic compounds while minimizing toxic components, thereby achieving better efficacy with reduced side effects
2Object-generated harmful factors
If natural compounds are developed to reduce side effects, then toxicity is reduced, but therapeutic efficacy may be limited
Solution Approach 1:
The patent merges three different herbal extracts (Asiasarum, Platycodon, and Cinnamomi) that each have independent anti-allergic mechanisms. By combining them in a 1:2:2 ratio, the formulation achieves synergistic enhancement of therapeutic effects while maintaining low toxicity, as each herb contributes different active compounds that work together
3Reliability
If mixed extract composition is optimized for Th2 cell differentiation inhibition, then anti-allergic effect is enhanced, but formulation complexity increases
Solution Approach 1:
The patent establishes specific extraction parameters (70% ethanol, 60-70°C, 3 hours) and a fixed herbal ratio (1:2:2) to standardize the production process. This parameter optimization ensures consistent Th2 cell differentiation inhibition while making the formulation reproducible and manufacturable, balancing efficacy with practical complexity
Data Source
AI summary
The present invention relates to a pharmaceutical composition for prevention or treatment of an allergic disease comprising a mixed extract of two or more selected from the group consisting of Asiasarum root, Platycodon root, and Cinnamomi ramulus as an active ingredient; a method for prevention or treatment of an allergic disease using the pharmaceutical composition; and a health functional food and a feed composition for improvement of an allergic disease. The composition and method of the invention can specifically inhibit the differentiation of Th2 cells and thus can be effectively used as a composition for prevention or treatment of an allergic disease.